Gefitinib as first line therapy in Malaysian patients with EGFR mutation-positive non-small-cell lung cancer: A single-center retrospective study

The present retrospective, single-center study evaluated the objective response rate (ORR) and progression-free survival (PFS) of epidermal growth factor receptor (EGFR) mutation-positive Malaysian patients with advanced lung adenocarcinoma treated with gefitinib. During May 2008 to July 2013, 33 pa...

Descripción completa

Detalles Bibliográficos
Autores principales: ABDULLAH, MATIN MELLOR, BHAT, AMIT, MOHAMED, AHMAD KAMAL, CHING, FOO YOKE, AHMED, NIDA, GANTOTTI, SANDEEP
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4812101/
https://www.ncbi.nlm.nih.gov/pubmed/27073548
http://dx.doi.org/10.3892/ol.2016.4322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4812101/
https://www.ncbi.nlm.nih.gov/pubmed/27073548
http://dx.doi.org/10.3892/ol.2016.4322

Ejemplares similares